Omega Healthcare Investors INC 8-K filings

Omega Healthcare Investors announced strong second quarter 2026 results, including $126 million in new investments, an increase in quarterly dividend, and raised full-year Adjusted FFO guidance.

Omega Healthcare Investors successfully concluded its 2026 Annual Meeting, re-electing all director nominees and updating beneficial ownership disclosures.

Omega Healthcare Investors, Inc. has announced significant leadership changes, with CEO C. Taylor Pickett and CFO Robert O. Stephenson retiring, and new appointments for President and CFO.

Omega Healthcare Investors announced robust first quarter 2026 financial results, including significant new investments and an increase in full-year Adjusted FFO guidance.

Omega Healthcare Investors, Inc. announced robust fourth quarter and full year 2025 financial results, marked by significant new investments, debt reduction, and improved operator coverage.

Omega Healthcare Investors, Inc. amended employment agreements for its named executive officers, extending terms and increasing compensation and severance for key leaders.

Omega Healthcare Investors, Inc. has initiated a new at-the-market equity offering program to sell up to $2 billion in common stock, replacing a prior agreement.

Omega Healthcare Investors, Inc. reported strong third-quarter 2025 financial results, including increased net income and Adjusted FFO, and raised its full-year AFFO guidance following significant new investments and a new credit facility.

Omega Healthcare Investors, Inc. has redeemed all $600 million of its 5.250% Senior Notes due 2026, terminating related obligations.

Omega Healthcare Investors, Inc. has successfully closed a new $2.3 billion senior unsecured credit facility and amended its existing $428.5 million term loan, enhancing liquidity and reducing borrowing costs.

Omega Healthcare Investors, Inc. announced the redemption of all its outstanding $600 million 5.250% Senior Notes due 2026 on October 15, 2025.

Omega Healthcare Investors announced robust second quarter 2025 financial results, including increased net income and FFO, driven by significant new investments and an improved outlook for operator performance, leading to an upward revision of its full-year Adjusted FFO guidance.

Omega Healthcare Investors, Inc. announced an update to its investor presentation, specifically revising the 'Operator Updates' slide to provide current information on its healthcare facility operators.

Omega Healthcare Investors, Inc. has successfully completed an underwritten public offering of $600 million in 5.200% Senior Notes due 2030, with proceeds earmarked for general corporate purposes including debt repayment and future healthcare real estate acquisitions.

Omega Healthcare Investors, Inc. has successfully priced an underwritten public offering of $600 million in 5.200% Senior Notes due 2030, with net proceeds earmarked for general corporate purposes including debt repayment and future acquisitions.

Omega Healthcare Investors, Inc. has filed a prospectus supplement to continue its Dividend Reinvestment and Common Stock Purchase Plan, registering an additional 22,447,054 shares of common stock for issuance.

Omega Healthcare Investors, Inc. announced that its stockholders approved an amendment to double the authorized common stock to 700 million shares, re-elected all director nominees, and ratified executive compensation and the independent auditor at its 2025 Annual Meeting.

Omega Healthcare Investors, Inc. announced the release of an updated investor presentation, featuring a revised 'Operator Updates' slide, available on its website.

Omega Healthcare Investors has updated its investor presentation, focusing on revised operator updates.

Omega Healthcare Investors announces positive first quarter results, highlighted by increased net income and adjusted FFO, leading to an increased full-year AFFO guidance.

Omega Healthcare Investors announces positive financial results for Q4 and full year 2024, driven by new investments and improved operator performance, while also providing adjusted FFO guidance for 2025.

Omega Healthcare Investors has appointed Matthew Gourmand as President and Vikas Gupta as Chief Investment Officer, while Daniel Booth steps down as COO and transitions to a consulting role.

Omega Healthcare Investors announced positive third-quarter results, highlighted by increased net income, new investments, and an improved full-year adjusted FFO guidance.

Omega Healthcare Investors has entered into a new at-the-market equity offering agreement to sell up to $1.25 billion of its common stock.

Omega Healthcare Investors announced a significant increase in net income and raised its full-year adjusted FFO guidance, driven by new investments and improved tenant performance.

Omega Healthcare Investors successfully held its annual meeting, electing all director nominees and ratifying Ernst & Young as its independent auditor for fiscal year 2024.

Omega Healthcare Investors announced an update on the restructuring of LaVie Care Centers, including a $10 million commitment to debtor-in-possession financing after LaVie filed for Chapter 11 bankruptcy.

Omega Healthcare Investors announced first quarter 2024 results, exceeding expectations with increased net income and new investments.

Omega Healthcare Investors has reached a proposed settlement in a shareholder derivative lawsuit, which includes corporate governance reforms and payment of attorney fees.

Omega Healthcare Investors has filed a new automatic shelf registration statement, replacing a previous one, to continue its dividend reinvestment and at-the-market equity offering programs.